BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 37402420)

  • 1. Pretransplantation EASIX Score Predicts Nonrelapse and Overall Mortality of Adult Patients Undergoing Single-Unit Unrelated Cord Blood Transplantation.
    Fujita S; Monna-Oiwa M; Kato S; Isobe M; Takahashi S; Nannya Y; Konuma T
    Transplant Cell Ther; 2023 Sep; 29(9):580.e1-580.e8. PubMed ID: 37402420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation.
    Sanchez-Escamilla M; Flynn J; Devlin S; Maloy M; Fatmi SA; Tomas AA; Escribano-Serrat S; Ponce D; Sauter CS; Giralt SA; Scordo M; Perales MA
    Bone Marrow Transplant; 2023 May; 58(5):498-505. PubMed ID: 36721042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study.
    Penack O; Luft T; Peczynski C; Benner A; Sica S; Arat M; Itäla-Remes M; Corral LL; Schaap NPM; Karas M; Raida L; Schroeder T; Dreger P; Metafuni E; Ozcelik T; Sandmaier BM; Kordelas L; Moiseev I; Schoemans H; Koenecke C; Basak GW; Peric Z
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-unit unrelated cord blood transplantation versus HLA-matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry-based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy.
    Konuma T; Itonaga H; Shimomura Y; Fujioka M; Aoki K; Uchida N; Onizuka M; Jinguji A; Tanaka M; Ueda Y; Katayama Y; Sawa M; Tanaka H; Nakamae H; Kawakita T; Maruyama Y; Takahashi S; Ishimaru F; Kanda J; Ichinohe T; Atsuta Y
    Hematol Oncol; 2024 Jan; 42(1):e3217. PubMed ID: 37592904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of IL-2 polymorphism rs2069762 on single-unit cord blood transplant outcomes.
    Konuma T; Hamatani-Asakura M; Monna-Oiwa M; Kato S; Isobe M; Yokoyama K; Takahashi S; Nannya Y
    Cytokine; 2024 Jul; 179():156636. PubMed ID: 38718489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
    Farina M; Scaini MC; Facchinetti A; Leoni A; Bernardi S; Catoni C; Morello E; Radici V; Frioni F; Campodonico E; Traverso G; Cavallaro G; Olivieri A; Galieni P; Renzo ND; Patriarca F; Carluccio P; Skert C; Maffini E; Pellizzeri S; Campisi G; Re F; Benedetti E; Rosato A; Almici C; Chiusolo P; Peccatori J; Malagola M; Poggiana C; Russo D
    Transplant Cell Ther; 2024 Jun; 30(6):580.e1-580.e14. PubMed ID: 38582286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complication.
    Dai H; Penack O; Radujkovic A; Schult D; Majer-Lauterbach J; Blau IW; Bullinger L; Jiang S; Müller-Tidow C; Dreger P; Luft T
    Bone Marrow Transplant; 2021 Jul; 56(7):1573-1583. PubMed ID: 33517355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Graft-versus-Host Disease Enterocolitis Following Cord Blood Transplantation is Real, with Poorly Understood Pathophysiology, and Requires Distinct Management, with Eventual Resolution without Immune Suppression.
    Horgan C; Bitetti S; Newbould M; Sethuraman C; Fagbemi A; Kala A; Williams N; Wynn R
    Transplant Cell Ther; 2024 Apr; 30(4):440.e1-440.e9. PubMed ID: 38052367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Adjusted Endothelial Activation and Stress Index for Coronavirus Disease 2019 at Admission Is a Reliable Predictor for 28-Day Mortality in Hospitalized Patients With Coronavirus Disease 2019.
    Pérez-García F; Bailén R; Torres-Macho J; Fernández-Rodríguez A; Jiménez-Sousa MÁ; Jiménez E; Pérez-Butragueño M; Cuadros-González J; Cadiñanos J; García-García I; Jiménez-González M; Ryan P; Resino S
    Front Med (Lausanne); 2021; 8():736028. PubMed ID: 34568391
    [No Abstract]   [Full Text] [Related]  

  • 11. Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan.
    Watanabe M; Kanda J; Volt F; Ruggeri A; Suzuki R; Rafii H; Kimura F; Cappelli B; Kondo E; Scigliuolo GM; Takahashi S; Kenzey C; Rivera-Franco MM; Okamoto S; Rocha V; Chevallier P; Sanz J; Fürst S; Cornelissen J; Milpied N; Uchida N; Sugio Y; Kimura T; Ichinohe T; Fukuda T; Mohty M; Peffault de Latour R; Atsuta Y; Gluckman E
    Blood Adv; 2024 Feb; 8(3):640-652. PubMed ID: 38100431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation.
    Vaughn JE; Storer BE; Armand P; Raimondi R; Gibson C; Rambaldi A; Ciceri F; Oneto R; Bruno B; Martin PJ; Sandmaier BM; Storb R; Sorror ML
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1418-24. PubMed ID: 25862589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation.
    Tolosa-Ridao C; Cascos E; Rodríguez-Lobato LG; Pedraza A; Suárez-Lledó M; Charry P; Solano MT; Martinez-Sanchez J; Cid J; Lozano M; Rosiñol L; Esteve J; Urbano-Ispizua Á; Fernández-Avilés F; Martínez C; Carreras E; Díaz-Ricart M; Rovira M; Salas MQ
    Bone Marrow Transplant; 2024 Mar; ():. PubMed ID: 38521885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant impact of antibiotic exposure on GI-GVHD, NRM, and GRFS following allogeneic HCT with non-myeloablative Flu-TBI conditioning.
    van Groningen LFJ; van Dorp S; Bremmers MEJ; Fazel S; Roeven MWH; Blijlevens NMA; van der Velden WJFM
    Leuk Lymphoma; 2024 Mar; ():1-8. PubMed ID: 38520720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Preexisting Diabetes.
    Rashid N; Gooley T; Boeckh M; Oshima MU; Chao JH; Hirsch IB; Mielcarek M
    Transplant Cell Ther; 2024 Apr; 30(4):417.e1-417.e9. PubMed ID: 38242443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.
    Wan BA; Lindo L; Mourad YA; Chung S; Forrest D; Kuchenbauer F; Nantel S; Narayanan S; Nevill T; Power M; Rodrigo J; Sanford D; Song K; Stubbins RJ; Sutherland H; Toze CL; White J; Roy C; Hay KA
    Cytotherapy; 2024 May; ():. PubMed ID: 38819367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an umbilical cord blood transplantation-specific nonrelapse mortality risk assessment score.
    Okada Y; Usui Y; Hayashi H; Nishikubo M; Toubai T; Uchida N; Tanaka M; Onizuka M; Takahashi S; Doki N; Uehara Y; Maruyama Y; Ishiwata K; Kawakita T; Sawa M; Eto T; Ishimaru F; Kato K; Fukuda T; Atsuta Y; Kanda J; Yakushijin K; Nakasone H
    Blood Adv; 2024 Mar; 8(6):1359-1368. PubMed ID: 38163321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and safety of the discontinuation of systemic immunosuppressive treatment after single-unit cord blood transplantation in adults.
    Konuma T; Monna-Oiwa M; Kato S; Isobe M; Nannya Y; Takahashi S
    Bone Marrow Transplant; 2024 May; ():. PubMed ID: 38740951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host Disease.
    Rashidi A; Shanley R; Holtan SG; MacMillan ML; Blazar BR; Khoruts A; Weisdorf DJ
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2190-2196. PubMed ID: 30454871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomagnesemia May Predict Better Survival and Reduced Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Savaş EM; Yegin ZA; Kök Mİ; Karayel HT; Özkurt ZN; Bozer MN; Çamoğlu M; Gülbahar Ö
    Transplant Proc; 2024 Mar; 56(2):386-393. PubMed ID: 38365511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.